Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
or

Cryo-Cell Intl Inc (CCEL)

Cryo-Cell Intl Inc (CCEL)
5.20 x 2 N/A x N/A
Post-market by (Cboe BZX)
5.43 -0.10 (-1.81%) 04/11/25 [NYSE Arca]
5.20 x 2 N/A x N/A
Post-market 5.43 unch (unch) 20:00 ET
Quote Overview for Fri, Apr 11th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
5.43
Day High
5.60
Open 5.55
Previous Close 5.53 5.53
Volume 2,100 2,100
Avg Vol 14,190 14,190
Stochastic %K 24.89% 24.89%
Weighted Alpha -35.16 -35.16
5-Day Change -1.02 (-15.81%) -1.02 (-15.81%)
52-Week Range 4.96 - 9.50 4.96 - 9.50
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 43,886
  • Shares Outstanding, K 8,082
  • Annual Sales, $ 31,990 K
  • Annual Income, $ 400 K
  • EBIT $ 4 M
  • EBITDA $ 5 M
  • 60-Month Beta 0.59
  • Price/Sales 1.40
  • Price/Cash Flow 30.84
  • Price/Book N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr N/A
See More
  • Average Estimate N/A
  • Number of Estimates N/A
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.96 +9.48%
on 04/08/25
Period Open: 6.51
6.99 -22.32%
on 03/14/25
-1.08 (-16.59%)
since 03/11/25
3-Month
4.96 +9.48%
on 04/08/25
Period Open: 7.10
8.79 -38.23%
on 02/07/25
-1.67 (-23.52%)
since 01/10/25
52-Week
4.96 +9.48%
on 04/08/25
Period Open: 7.27
9.50 -42.83%
on 05/15/24
-1.84 (-25.34%)
since 04/11/24

Most Recent Stories

More News
Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2023 Financial Results

Cryo-Cell International, Inc. (NYSE American LLC: CCEL ) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal first...

CCEL : 5.43 (-1.77%)
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2022 Financial Results

OLDSMAR, Fla., July 11, 2022 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (the “Company”), the world’s first...

CCEL : 5.43 (-1.77%)
Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2022 Financial Results

OLDSMAR, Fla., April 13, 2022 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (OTC:QB Markets Group Symbol: CCEL) (the “Company”), the world’s first...

CCEL : 5.43 (-1.77%)
Cord Blood Banking Leader Cryo-Cell Announces Extravault Biorepository Service

OLDSMAR, Fla., March 16, 2022 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (the “Company”), the world’s first...

CCEL : 5.43 (-1.77%)
Cryo-Cell Shares Its 2021 Annual Letter to Shareholders

OLDSMAR, Fla., March 09, 2022 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (the “Company”), the world’s first...

CCEL : 5.43 (-1.77%)
Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2021

OLDSMAR, Fla., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (the “Company”), the world’s first...

CCEL : 5.43 (-1.77%)
Cord Blood Banking Leader Cryo-Cell Announces Its Intent to Advance Clinical Trials

OLDSMAR, Fla., Oct. 27, 2021 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (the “Company”), the world’s first...

CCEL : 5.43 (-1.77%)
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2021 Financial Results

OLDSMAR, Fla., Oct. 15, 2021 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (the “Company”), the world’s first...

CCEL : 5.43 (-1.77%)
Cryo-Cell International Announces Changes To Its Board of Directors

MIAMI, Sept. 20, 2021 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (Nasdaq:CCEL), the leader in cord blood and cord tissue cryopreservation services, announces the appointment of Mr. Mark Portnoy...

CCEL : 5.43 (-1.77%)
Cryo-Cell International Announces Uplisting to The Nasdaq Capital Market

Cryo-Cell International, Inc. (Symbol CCEL), The Leader In Cord Blood And Cord Tissue Cryopreservation Services, Today Announced That The Company’s Common Stock Has Been Approved For Listing On The Nasdaq...

CCEL : 5.43 (-1.77%)

Business Summary

CRYO-CELL International is engaged in cryogenic cellular storage and the design and developmentof cellular storage devices. They currently focus on the processing and preservation of umbilical cord blood stem cells for autologous/sibling use. They have pioneered several technologies that allow for the...

See More

Key Turning Points

3rd Resistance Point 5.71
2nd Resistance Point 5.66
1st Resistance Point 5.54
Last Price 5.43
1st Support Level 5.37
2nd Support Level 5.32
3rd Support Level 5.20

See More

52-Week High 9.50
Fibonacci 61.8% 7.76
Fibonacci 50% 7.23
Fibonacci 38.2% 6.69
Last Price 5.43
52-Week Low 4.96

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar